Healthcare & Life Sciences
Cambridge Molecular Diagnostics Ltd
United Kingdom
series-b
series-b
Stage
1
Investors
About
Cambridge Molecular Diagnostics Ltd develops molecular diagnostic solutions for clinical applications to enhance disease detection and improve patient outcomes.
Explore Cambridge Molecular Diagnostics Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.